Fig. 6From: Role of fused PET/CT compared to the standard contrast-enhanced CT in the follow-up assessment of the treated gastric malignancyAxial and coronal post-contrast CT, PET, and PET/CT images for a 42-year-old female patient diagnosed as distal oesophageal and gastric fundus mural thickening by the upper endoscopy and this was pathologically proven to be lymphoma. Images a–c showed an ill-defined metabolically active lower oesophageal, gastro-oesophageal and gastric fundus mural thickening (yellow arrows) with SUVmax = 5.4. Images d–f showed multiple metabolically active supradiaphragmatic and infradiaphragmatic lymphadenopathy (red arrows), the most active lesion is seen in the mediastinal group with SUVmax = 13.8. Images g–i showed metabolically active bilateral iliac bone lesions with no gross corresponding CT findings (blue arrows); their measured SUVmax = 10.4Back to article page